These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19059572)

  • 41. Stent thrombosis: an overview.
    Centemero MP; Stadler JR
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):599-615. PubMed ID: 22651836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stents and antiplatelet therapy.
    Fassa AA; Urban P
    Adv Cardiol; 2012; 47():114-24. PubMed ID: 22906907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bare metal stent thrombosis 13 years after implantation.
    Sarkees ML; Bavry AA; Galla JM; Bhatt DL
    Cardiovasc Revasc Med; 2009; 10(1):58-9. PubMed ID: 19159857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stent thrombosis: role of compliance and nonresponsiveness to antiplatelet therapy.
    Gurbel PA; Tantry US
    Rev Cardiovasc Med; 2007; 8 Suppl 1():S19-26. PubMed ID: 17401307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study.
    Burzotta F; Parma A; Pristipino C; Manzoli A; Belloni F; Sardella G; Rigattieri S; Danesi A; Mazzarotto P; Summaria F; Romagnoli E; Prati F; Trani C; Crea F
    Eur Heart J; 2008 Dec; 29(24):3011-21. PubMed ID: 18987096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stent thrombosis: a poor man's disease?
    Danenberg HD; Marincheva G; Varshitzki B; Nassar H; Lotan C
    Isr Med Assoc J; 2009 Sep; 11(9):529-32. PubMed ID: 19960845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era.
    Rodriguez AE
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):561-76. PubMed ID: 19712016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessing the landscape of stent thrombosis: the drug-eluting versus bare-metal stent controversy.
    Rizik DG; Klassen KJ
    Am J Cardiol; 2008 Nov; 102(9 Suppl):4J-11J. PubMed ID: 18928786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Is stent thrombosis the new Achilles heel of interventional cardiology? State of the Art clinical trials, causes and approaches for prevention].
    Grumann T; Diehl P; Bode C; Moser M
    Hamostaseologie; 2007 Dec; 27(5):344-50. PubMed ID: 18060244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimizing the impact of primary percutaneous coronary intervention in acute myocardial infarction.
    Satler LF
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):201. PubMed ID: 21290554
    [No Abstract]   [Full Text] [Related]  

  • 54. Focused clinical review: periprocedural management of antiplatelet therapy in patients with coronary stents.
    Bell B; Layland J; Poon K; Spaulding C; Walters D
    Heart Lung Circ; 2011 Jul; 20(7):438-45. PubMed ID: 21493140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Very late bare-metal stent thrombosis, rare but stormy!
    Ali M; McDonald K
    J Invasive Cardiol; 2011 Aug; 23(8):E208-10. PubMed ID: 21828410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: a survey of 374 interventional cardiologists.
    Khair T; Garcia B; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2011; 12(2):99-104. PubMed ID: 21421188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stent thrombosis.
    Holmes DR; Kereiakes DJ; Garg S; Serruys PW; Dehmer GJ; Ellis SG; Williams DO; Kimura T; Moliterno DJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1357-65. PubMed ID: 20946992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DES in SVGs: safe and at least short-term effective.
    Hillegass WB
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):356-7. PubMed ID: 21328680
    [No Abstract]   [Full Text] [Related]  

  • 59. [The bioresorbable coronary stent: a revolution].
    Koegler F; De Benedetti E
    Rev Med Suisse; 2013 Apr; 9(381):775-8. PubMed ID: 23659156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eosinophilic responses to stent implantation and the risk of Kounis hypersensitivity associated coronary syndrome.
    Kounis NG; Giannopoulos S; Tsigkas GG; Goudevenos J
    Int J Cardiol; 2012 Apr; 156(2):125-32. PubMed ID: 21700348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.